US Patent 11426413 Oral liquid compositions including chlorpromazine
Patent 11426413 was granted and assigned to Genus Lifesciences Inc. on August, 2022 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11426413 Oral liquid compositions including chlorpromazine
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.